High Performance Beverages Co (TBEV) financial statements (2021 and earlier)

Company profile

Business Address 5137 E. ARMOR ST
CAVE CREEK, AZ 85331
State of Incorp. NV
Fiscal Year End July 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

4/30/2016
Q3
1/31/2016
Q2
10/31/2015
Q1
7/31/2015
Q4
4/30/2015
Q3
1/31/2015
Q2
10/31/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21720144308398283
Cash and cash equivalents21720144308398283
Receivables008    
Inventory, net of allowances, customer advances and progress billings192123    
Inventory192123    
Total current assets:213851144308398283
Noncurrent Assets
TOTAL ASSETS:213851144308398283
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,017882797  306284
Accrued liabilities     306284
Other undisclosed accounts payable and accrued liabilities1,017882797    
Debt7777777
Derivative instruments and hedges, liabilities2,3853,1302,1791,2041,5622,0801,535
Other undisclosed current liabilities    2,5582,3521,560
Total current liabilities:3,4084,0192,9821,2114,1274,7443,386
Noncurrent Liabilities
Other undisclosed liabilities3,3983,3873,3044,116   
Total liabilities:6,8067,4066,2865,3264,1274,7443,386
Stockholders' equity
Stockholders' equity attributable to parent, including:(6,784)(7,368)(6,235)(5,182)(3,819)(4,347)(3,404)
Preferred stock00000  
Common stock215494,3002,4001,2852,1281,967
Common stock, value, subscriptions226256249148148223223
Additional paid in capital7,4257,3073,0723,2584,3193,0192,721
Accumulated deficit(14,651)(14,980)(13,856)(10,989)(9,571)(9,717)(8,013)
Other undisclosed stockholders' equity attributable to parent      (301)
Other undisclosed stockholders' equity      301
Total stockholders' equity:(6,784)(7,368)(6,235)(5,182)(3,819)(4,347)(3,103)
TOTAL LIABILITIES AND EQUITY:213851144308398283

Income statement (P&L) ($ in thousands)

4/30/2016
Q3
1/31/2016
Q2
10/31/2015
Q1
7/31/2015
Q4
4/30/2015
Q3
1/31/2015
Q2
10/31/2014
Q1
Revenues61129    
Cost of revenue
(Cost of Goods and Services Sold)
(6)(10)(29)    
Gross profit:(0)10    
Operating expenses(285)(159)(540)(525)(283)(662)(531)
Other operating expense, net
(Other Expenses)
      (1,337)
Operating loss:(286)(158)(540)(525)(283)(662)(1,868)
Nonoperating income (expense)6159672,326(4,792)(429)1,042306
Debt instrument, convertible, beneficial conversion feature      306
Other nonoperating income (expense)    (429)1,042 
Interest and debt expense736(480)461(2,764)10976(176)
Net income (loss):1,0653292,247(8,081)(604)456(1,738)
Other undisclosed net income (loss) attributable to parent(736)(1,454)(5,114)6,663749(2,159)(130)
Net income (loss) available to common stockholders, diluted:330(1,125)(2,867)(1,418)146(1,703)(1,868)

Comprehensive Income ($ in thousands)

4/30/2016
Q3
1/31/2016
Q2
10/31/2015
Q1
7/31/2015
Q4
4/30/2015
Q3
1/31/2015
Q2
10/31/2014
Q1
Net income (loss):1,0653292,247(8,081)(604)456(1,738)
Comprehensive income (loss), net of tax, attributable to parent:1,0653292,247(8,081)(604)456(1,738)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: